Author:
Colbert Roghan Donohue,Gaya Daniel,Hale Gordon,Rickaby William
Abstract
We present the rare case of a 61-year-old man with Crohn’s disease who developed a cutaneous Kaposi’s sarcoma in the setting of long-term treatment with 6-mercaptopurine. Deciding on the best course of management provided a clinical challenge in an ‘evidence-light’ area. Relevant case reports and guidelines were reviewed. In general, the withdrawal of immunosuppressive therapy is advised; however, a multidisciplinary, case-by-case approach is also emphasised. The patient’s lesion was removed and, following collaborative discussion, immunosuppression was continued post resection. This is thought to be the first reported case involving a Kaposi’s sarcoma in inflammatory bowel disease where immune therapy was not subsequently discontinued.
Reference40 articles.
1. Aboulafia D . Kaposi's sarcoma. BMJ best practice, 2019. Available: https://bestpractice.bmj.com/topics/en- gb/1031 [Accessed 28 Dec 2020].
2. Kaposi's sarcoma in association with Behcet's disease: case report and literature review;Mezalek;Semin Arthritis Rheum,2007
3. Myasthenia gravis developing in an HIV-negative patient with Kaposi's sarcoma;Mantero;Neurol Sci,2013
4. Iatrogenic Kaposi's sarcoma following therapy for rheumatoid arthritis;Bergler-Czop;Postepy Dermatol Alergol,2016
5. A case of classic Kaposi sarcoma in an immunocompetent human immunodeficiency virus-negative Dominican man;Gupta;SAGE Open Med Case Rep,2020
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献